BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 30205505)

  • 1. What's New in Gastric Cancer: The Therapeutic Implications of Molecular Classifications and Future Perspectives.
    Tirino G; Pompella L; Petrillo A; Laterza MM; Pappalardo A; Caterino M; Orditura M; Ciardiello F; Galizia G; De Vita F
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30205505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibodies-based treatment in gastric cancer: current status and future perspectives.
    Roviello G; Polom K; Petrioli R; Marano L; Marrelli D; Paganini G; Savelli V; Generali D; De Franco L; Ravelli A; Roviello F
    Tumour Biol; 2016 Jan; 37(1):127-40. PubMed ID: 26566626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeted therapies in metastatic gastric cancer: Current knowledge and future perspectives.
    Pellino A; Riello E; Nappo F; Brignola S; Murgioni S; Djaballah SA; Lonardi S; Zagonel V; Rugge M; Loupakis F; Fassan M
    World J Gastroenterol; 2019 Oct; 25(38):5773-5788. PubMed ID: 31636471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How Can Gastric Cancer Molecular Profiling Guide Future Therapies?
    Corso S; Giordano S
    Trends Mol Med; 2016 Jul; 22(7):534-544. PubMed ID: 27260398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Gastric carcinoma: an evolutionary scenario.].
    Gelsomino F; Spallanzani A; De Vita F; Di Bartolomeo M; Gavazzi C; Rimassa L; Cascinu S
    Recenti Prog Med; 2017 Mar; 108(3):120-127. PubMed ID: 28398405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current and emerging therapies in unresectable and recurrent gastric cancer.
    Jou E; Rajdev L
    World J Gastroenterol; 2016 May; 22(20):4812-23. PubMed ID: 27239108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Challenges in molecular targeted therapy for gastric cancer: considerations for efficacy and safety.
    Narita Y; Muro K
    Expert Opin Drug Saf; 2017 Mar; 16(3):319-327. PubMed ID: 27976952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison and applicability of molecular classifications for gastric cancer.
    Serra O; Galán M; Ginesta MM; Calvo M; Sala N; Salazar R
    Cancer Treat Rev; 2019 Jul; 77():29-34. PubMed ID: 31195213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dawn of precision medicine on gastric cancer.
    Ishii T; Kawazoe A; Shitara K
    Int J Clin Oncol; 2019 Jul; 24(7):779-788. PubMed ID: 30976939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metastatic stomach cancer: Clinical trials in Asia and in Occident].
    Bui QL; Grazziotin-Soares D; Hasiniatsy RE; Trinh HS; Richard S; Lotz JP; Gligorov J; Khalil A
    Bull Cancer; 2018 Oct; 105(10):932-943. PubMed ID: 30243480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted Therapies in Advanced Gastric Cancer.
    Patel TH; Cecchini M
    Curr Treat Options Oncol; 2020 Jul; 21(9):70. PubMed ID: 32725377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating gastric cancer genomics into targeted therapies.
    Ang YL; Yong WP; Tan P
    Crit Rev Oncol Hematol; 2016 Apr; 100():141-6. PubMed ID: 26947813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision medicine in gastric cancer.
    Bonelli P; Borrelli A; Tuccillo FM; Silvestro L; Palaia R; Buonaguro FM
    World J Gastrointest Oncol; 2019 Oct; 11(10):804-829. PubMed ID: 31662821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted therapy in advanced gastric carcinoma: the future is beginning.
    Schinzari G; Cassano A; Orlandi A; Basso M; Barone C
    Curr Med Chem; 2014; 21(8):1026-38. PubMed ID: 24304282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Gastric Cancer.
    Strand MS; Lockhart AC; Fields RC
    Surg Clin North Am; 2017 Apr; 97(2):345-370. PubMed ID: 28325191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted therapy in gastric cancer.
    Thiel A; Ristimäki A
    APMIS; 2015 May; 123(5):365-72. PubMed ID: 25706252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gastric Carcinoma at the Era of Targeted Therapies.
    Dreanic J; Dhooge M; Sion E; Brezault C; Chaussade S; Coriat R
    Curr Drug Targets; 2016; 17(15):1818-1826. PubMed ID: 25944013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reproduction of the Cancer Genome Atlas (TCGA) and Asian Cancer Research Group (ACRG) Gastric Cancer Molecular Classifications and Their Association with Clinicopathological Characteristics and Overall Survival in Moroccan Patients.
    Nshizirungu JP; Bennis S; Mellouki I; Sekal M; Benajah DA; Lahmidani N; El Bouhaddouti H; Ibn Majdoub K; Ibrahimi SA; Celeiro SP; Viana-Pereira M; Munari FF; Ribeiro GG; Duval V; Santana I; Reis RM
    Dis Markers; 2021; 2021():9980410. PubMed ID: 34367379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New therapeutic options opened by the molecular classification of gastric cancer.
    Chivu-Economescu M; Matei L; Necula LG; Dragu DL; Bleotu C; Diaconu CC
    World J Gastroenterol; 2018 May; 24(18):1942-1961. PubMed ID: 29760539
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Personalised Treatment in Gastric Cancer: Myth or Reality?
    Tarazona N; Gambardella V; Huerta M; Roselló S; Cervantes A
    Curr Oncol Rep; 2016 Jul; 18(7):41. PubMed ID: 27215435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.